The medicalisation of prevention: health promotion is more than a pill a day

References

[1]  Chow CK, Rodgers A (2016) Lost in translation: the gap between what we know and what we do about cardiovascular disease. Med J Aust 204, 291–2.
| Lost in translation: the gap between what we know and what we do about cardiovascular disease.Crossref | GoogleScholarGoogle Scholar |

[2]  Australian Institute of Health and Welfare (AIHW). Australian Burden of Disease Study: Impact and causes of illness and death in Australia 2011. Canberra: AIHW; 2016.

[3]  Corbi G, Conti V, Filippelli A, Di Costanzo A, Ferrara N (2015) The role of physical activity on the prevention of cognitive impairment. Transl Med UniSa 13, 42–6.

[4]  Si S, Boyle T, Heyworth J, Glass DC, Saunders C, Fritschi L (2015) Lifetime physical activity and risk of breast cancer in pre-and post-menopausal women. Breast Cancer Res Treat 152, 449–62.
| Lifetime physical activity and risk of breast cancer in pre-and post-menopausal women.Crossref | GoogleScholarGoogle Scholar |

[5]  Song M, Giovannucci E (2016) Preventable incidence and mortality of carcinoma associated with lifestyle factors among white adults in the United States JAMA Oncol
| Preventable incidence and mortality of carcinoma associated with lifestyle factors among white adults in the United StatesCrossref | GoogleScholarGoogle Scholar |

[6]  Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, et al (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368, 1279–90.
| Primary prevention of cardiovascular disease with a Mediterranean diet.Crossref | GoogleScholarGoogle Scholar |

[7]  Puska P (2010) From Framingham to North Karelia: from descriptive epidemiology to public health action. Prog Cardiovasc Dis 53, 15–20.
| From Framingham to North Karelia: from descriptive epidemiology to public health action.Crossref | GoogleScholarGoogle Scholar |

[8]  Khan LK, Sobush K, Keener D, Goodman K, Lowry A, Kakietek J, et al (2009) Recommended community strategies and measurements to prevent obesity in the United States. MMWR Recomm Rep 58, 1–26.

[9]  (2016) Editorial: Beat diabetes: an urgent call for global action. Lancet 387, 1483
| Editorial: Beat diabetes: an urgent call for global action.Crossref | GoogleScholarGoogle Scholar |

[10]  Wald NJ, Law MR (2003) A strategy to reduce cardiovascular disease by more than 80%. BMJ 326, 1419–23.
| A strategy to reduce cardiovascular disease by more than 80%.Crossref | GoogleScholarGoogle Scholar |

[11]  Martí-Carvajal AJ, Sola I, Lathyris D, Salanti G (2009) Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev CD006612

[12]  Kunutsor SK, Seidu S, Khunti K (2016) Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials. Diabet Med
| Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.Crossref | GoogleScholarGoogle Scholar |

[13]  Bibbins-Domingo K, Force USPST (2016) Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: u.s. preventive services task force recommendation statement. Ann Intern Med 164, 836–45.
| Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: u.s. preventive services task force recommendation statement.Crossref | GoogleScholarGoogle Scholar |

[14]  Jancey J, Barnett L, Smith J, Binns C, Howat P (2016) We need a comprehensive approach to health promotion. Health Promot J Austr 27, 1–3.

[15]  Yusuf S, Lonn E, Pais P, Bosch J, Lopez-Jaramillo P, Zhu J, et al (2016) Blood-pressure and cholesterol lowering in persons without cardiovascular disease. N Engl J Med 374, 2032–43.
| Blood-pressure and cholesterol lowering in persons without cardiovascular disease.Crossref | GoogleScholarGoogle Scholar |

[16]  Cohn JN (2015) Prevention of cardiovascular disease. Trends Cardiovasc Med 25, 436–42.
| Prevention of cardiovascular disease.Crossref | GoogleScholarGoogle Scholar |

[17]  Anyanwagu U, Idris I, Donnelly R (2016) Drug-induced diabetes mellitus: evidence for statins and other drugs affecting glucose metabolism. Clin Pharmacol Ther 99, 390–400.
| Drug-induced diabetes mellitus: evidence for statins and other drugs affecting glucose metabolism.Crossref | GoogleScholarGoogle Scholar |

[18]  Thomas M, Mann J (1998) Increased thrombotic vascular events after change of statin. Lancet 352, 1830–1.
| Increased thrombotic vascular events after change of statin.Crossref | GoogleScholarGoogle Scholar |

[19]  Huffman MD (2015) The polypill: from promise to pragmatism. PLoS Med 12, e1001862
| The polypill: from promise to pragmatism.Crossref | GoogleScholarGoogle Scholar |

[20]  Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al (2016) Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 387, 957–67.
| Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.Crossref | GoogleScholarGoogle Scholar |

[21]  Dicpinigaitis PV (2006) Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest 129, S169–73.
| Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines.Crossref | GoogleScholarGoogle Scholar |

[22]  Sydney University. Media statement. Closure of Beach Program after 18 years. 2016 http://sydney.edu.au/medicine/fmrc/media/BEACH-closure-2016-04.php [verified 16 June 2016].

[23]  Smith JA, Crawford G, Signal L (2016) The case of national health promotion policy in Australia: where to now? Health Promot J Austr 27, 61–5.

[24]  Binns C, Howat P, Jancey J (2014) Health promotion success in Australia and a note of warning. Health Promot J Austr 25, 157–9.
| Health promotion success in Australia and a note of warning.Crossref | GoogleScholarGoogle Scholar |